| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 94.52B | 89.09B | 73.89B | 77.32B | 78.34B | 69.96B |
| Gross Profit | 4.32B | 3.93B | 3.50B | 3.37B | 3.64B | 3.13B |
| EBITDA | 1.87B | 1.75B | 1.62B | 1.47B | 1.79B | 1.54B |
| Net Income | 1.21B | 1.05B | 922.03M | 823.07M | 1.31B | 1.07B |
Balance Sheet | ||||||
| Total Assets | 40.51B | 38.39B | 35.02B | 34.77B | 32.18B | 29.43B |
| Cash, Cash Equivalents and Short-Term Investments | 6.19B | 5.44B | 4.13B | 8.23B | 4.13B | 4.05B |
| Total Debt | 10.02B | 9.68B | 8.44B | 8.65B | 6.53B | 7.01B |
| Total Liabilities | 30.90B | 29.52B | 26.80B | 27.11B | 24.27B | 22.60B |
| Stockholders Equity | 9.32B | 8.64B | 8.22B | 7.66B | 7.91B | 6.83B |
Cash Flow | ||||||
| Free Cash Flow | 863.39M | 1.69B | 601.41M | -171.90M | 527.57M | 2.42B |
| Operating Cash Flow | 994.54M | 1.82B | 640.23M | -147.87M | 580.07M | 2.45B |
| Investing Cash Flow | 331.70M | -300.93M | 137.76M | -517.66M | -47.04M | -36.37M |
| Financing Cash Flow | -1.36B | -837.13M | -1.37B | 1.57B | -942.10M | -1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$2.77B | 6.38 | 14.95% | 8.89% | -0.06% | -6.11% | |
68 Neutral | HK$12.01B | 9.74 | 13.99% | 3.21% | 18.23% | 38.95% | |
66 Neutral | HK$1.40B | 11.90 | 11.96% | 6.74% | -5.58% | 22.50% | |
65 Neutral | HK$2.96B | 7.47 | 13.40% | 4.42% | 6.01% | 9.76% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | HK$6.52B | 26.46 | 5.41% | ― | 33.59% | -15.98% | |
53 Neutral | HK$456.92M | 30.58 | 5.11% | ― | 14.50% | 247.50% |
VSTECS Holdings Limited has clarified additional details in its 2024 annual report regarding 4,540,000 shares repurchased during the year and held as treasury shares for potential resale or to satisfy future share grants, and it confirmed that its 2015 share option scheme had roughly six months of life remaining at year-end 2024 with no options then granted, exercised, cancelled, lapsed or outstanding, leaving 152,542,799 options available for grant under the scheme. In its 2025 interim reporting, the company disclosed that during the first half of 2025 it granted 29,400,000 share options to all directors and 65 full‑time employees, tied to ambitious revenue growth targets for a specified subsidiary over 2025–2027, and noted that the scheme has since expired with no options remaining available for grant, underscoring a strategic use of equity incentives to drive performance ahead of the scheme’s expiry while maintaining previously reported financial information unchanged.
The most recent analyst rating on (HK:0856) stock is a Hold with a HK$9.00 price target. To see the full list of analyst forecasts on VSTECS Holdings Limited stock, see the HK:0856 Stock Forecast page.